FDA new grant funding opportunity

The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds for fiscal years (FY) 2021 – FY 2022 to support innovative and efficient clinical trials for rare diseases and conditions. These studies are intended to provide acceptable data to the FDA that will substantially contribute to Read more about FDA new grant funding opportunity[…]

Virtual coffee with patient organisations and Share4Rare

World Duchenne Organization is involved in Share4Rare, a platform to boost rare disease research and recently, a new and improved role was introduced to the platform for patient organisations (POs). To share this important update and engage with rare disease POs, there will be a virtual meeting on a webinar for Patient Organisations in Rare Read more about Virtual coffee with patient organisations and Share4Rare[…]

European Biotech Week

 European Biotech Week: Celebrating Innovation The European Biotech Week established itself as a week of celebrations of science and biotech. This year, #biotechweek will be from 28 September to 4 October 2020,  start planning your #biotech event and register it with #EuropeanBiotechWeek. It can be anything, from a science cafe to a seminar, an artistic performance, Read more about European Biotech Week[…]

ELIXIR All Hands Online meeting 2020: EJP RD workshop

EJP RD activities that will be introduced during the sixth ELIXIR All Hands Online meeting 2020 that will take place virtually 8 -10 June 2020. The meeting brings together members of the ELIXIR community from across the ELIXIR Nodes, and collaborators from partner organisations, in order to review ELIXIR’s achievements and activities so far and discuss Read more about ELIXIR All Hands Online meeting 2020: EJP RD workshop[…]

COVID-19 Pandemic Readiness: Let’s not reinvent the wheel – European Medical Research Infrastructures are part of the global response

The European Commission led a highly successful round of funding for diagnostics, treatments and vaccines against coronavirus. These resources must be used in the most efficient way possible. The best way is via cross-border, multi-sector and multi-disciplinary research collaboration based on existing networks, to reach a scale of partnerships and coordination that has yet to Read more about COVID-19 Pandemic Readiness: Let’s not reinvent the wheel – European Medical Research Infrastructures are part of the global response[…]

EJP RD at the ECRD Conference

EJP RD is participating at the ECRD online conference that takes place today and tomorrow. In particular, tomorrow our coordinator, Dr. Daria Julkowska, will be one of the speakers presenting during SESSION 0503: “From Research to Access: Is a European Collaborative Approach Possible?” which is part of the” THEME 5 ACHIEVING THE TRIPLE AS BY 2030: Read more about EJP RD at the ECRD Conference[…]

Covid-19 Global Response – Communication Toolkit

On 4 May, the European Union joined forces with global partners to kick-start the Coronavirus Global Response, a worldwide pledging effort to raise €7.5 billion of funding to rapidly develop and deploy universally available and affordable diagnostics, treatments, and vaccines against the Covid-19. The opening event already raised €7.4 billion, including a significant contribution of Read more about Covid-19 Global Response – Communication Toolkit[…]

GA4GH 8th Plenary is going virtual!

GA4GH 8th Plenary will now be completely virtual, save the dates: September 29 – 30 2020.  The 8th Plenary will bring together organizations and stakeholders from the genomics and health community for two days of keynotes, talks, updates, and workshops that will focus on advancing development work for the immediate data sharing needs of the community. Stay tuned for more details, Read more about GA4GH 8th Plenary is going virtual![…]